Asthma and chronic rhinosinusitis with nasal polyps (CRSwNPs) are coexisting diseases that are multifactorial. The rural environment seems to protect from atopy, but its relation with nonatopic airway inflammations has been less investigated. Indoleamine 2,3-dioxygenase (IDO) is an enzyme involved in the catabolism of the essential amino acid tryptophan (Trp) to kynurenine (Kyn). Low IDO activity has been previously observed in atopy and asthma. The objective was to investigate the relationships of IDO activity, eosinophils, and cofactors during asthma and/or CRSwNPs.
Methods
A Finnish population-based cohort of adult asthmatic patients (n = 245) and nonasthmatic patients (n = 405) was used. The presence of asthma and atopy were based on patient history and standardized diagnostic tests. The presence of acetyl salicylic acid intolerance, doctor-diagnosed NPs, and countryside environment during childhood were based on a questionnaire report. Serum IDO activity was evaluated by assessing the Kyn/Trp ratio by liquid chromatography.
Results
Low IDO activity was associated significantly with atopy, CRSwNPs, and an urban background. IDO activity did not correlate with pulmonary function. As expected, CRSwNPs was more frequent among asthmatic patients. A rural background has a protective effect from atopy and atopic asthma but it did not affect the prevalence of CRSwNPs or nonatopic asthma.
Conclusion
Low IDO activity might result from the urban environment and influence the development of the atopic phenotype. On the other hand, low IDO activity, found in CRSwNPs, does not seem to be related to the urban background an us may result from other, still unknown, factors.
Get full access to this article
View all access options for this article.
References
1.
BraunstahlG.J.United airways concept: What does it teach us about systemic inflammation in airways disease?Proc Am Thorac Soc6: 652–654, 2009.
2.
BrozekJ.L., BousquetJ., Baena-CagnaniC.E.Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines: 2010 Revision.J Allergy Clin Immunol126: 466–476, 2010.
3.
FokkensW.J., LundV.J., MullolJ.European position paper on rhinosinusitis and nasal polyps 2012.Rhinol Suppl23: 1–298, 2012.
4.
FengC.H., MillerM.D., and SimonR.A.The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis.Am J Rhinol Allergy26: 187–190, 2012.
5.
LinD.C., ChandraR.K., TanB.K.Association between severity of asthma and degree of chronic rhinosinusitis.Am J Rhinol Allergy25205–208, 2011.
6.
HolgateS.T.The airway epithelium is central to the pathogenesis of asthma.Allergol Int57: 1–10, 2008.
7.
AgacheI., AkdisC., JutelM., and VirchowJ.C.Untangling asthma phenotypes and endotypes.Allergy67: 835–846, 2012.
8.
ToT., StanojevicS., MooresG., GershonA.S.Global asthma prevalence in adults: Findings from the cross-sectional world health survey.BMC Public Health.12: 204.
9.
HastanD., FokkensW.J., BachertC.Chronic rhinosinusitis in Europe—An underestimated disease. A GA(2)LEN study.Allergy66: 1216–1223, 2011.
10.
HanselT.T., JohnstonS.L., and OpenshawP.J.Microbes and mucosal immune responses in asthma.Lancet381: 861–873, 2013.
11.
EgeM.J., MayerM., NormandA.C.Exposure to environmental microorganisms and childhood asthma.N Engl J Med364: 701–709, 2011.
12.
HanskiI., von HertzenL., FyhrquistN.Environmental biodiversity, human microbiota, and allergy are interrelated.Proc Natl Acad Sci U S A109: 8334–8339, 2012.
13.
Van BruaeneN., Perez-NovoC.A., BasinskiT.M.T-cell regulation in chronic paranasal sinus disease.J Allergy Clin Immunol121: 1435–1441, 1441.e1–3, 2008.
14.
JarvisD., NewsonR., LotvallJ.Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe.Allergy67: 91–98, 2012.
15.
Van ZeleT., ClaeysS., GevaertP.Differentiation of chronic sinus diseases by measurement of inflammatory mediators.Allergy61: 1280–1289, 2006.
16.
ChangJ.E., WhiteA., SimonR.A., and StevensonD.D.Aspirin-exacerbated respiratory disease: Burden of disease.Allergy Asthma Proc33: 117–121, 2012.
MunnD.H., ShafizadehE., AttwoodJ.T.Inhibition of T cell proliferation by macrophage tryptophan catabolism.J Exp Med189: 1363–1372, 1999.
19.
MellorA.L., SivakumarJ., ChandlerP.Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.Nat Immunol2: 64–68, 2001.
BelladonnaM.L., OrabonaC., GrohmannU., and PuccettiP.TGF-beta and kynurenines as the key to infectious tolerance.Trends Mol Med15: 41–49, 2009.
22.
PallottaM.T., OrabonaC., VolpiC.Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.Nat Immunol12: 870–878, 2011.
23.
DäubenerW., and MacKenzieC.R.IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism.Adv Exp Med Biol467: 517–524, 1999.
ManeechotesuwanK., SupawitaS., KasetsinsombatK.Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.J Allergy Clin Immunol121: 43–50, 2008.
26.
RaitalaA., KarjalainenJ., OjaS.S.Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.Mol Immunol43: 1054–1056, 2006.
27.
HonkanenT., LuukkainenA., LehtonenM.Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis with nasal polyps and antrochoanal polyps.Rhinology49: 356–363, 2011.
28.
LuukkainenA., KarjalainenJ., HonkanenT.Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: A case-control study.Clin Transl Allergy1: 17, 2011.
29.
KarjalainenJ., HulkkonenJ., PessiT.The IL1A genotype associates with atopy in nonasthmatic adults.J Allergy Clin Immunol110: 429–434, 2002.
30.
LaichA., NeurauterG., WidnerB., and FuchsD.More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC.Clin Chem48: 579–581, 2002.
31.
HanD.H., KimS.W., ChoS.H.Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp.Allergy64: 118–122, 2009.
32.
AhnY., AnS.Y., WonT.B.Nasal polyps: An independent risk factor for bronchial hyperresponsiveness in patients with allergic rhinitis.Am J Rhinol Allergy24: 359–363, 2010.
33.
VasilyevaE.D., KaledinV., NikolinV.P.Accelerated rejection of the second transplants of immunogenic tumor in mice under inhibition of indoleamine 2,3-dioxygenase activity by ethyl pyruvate.Exp Oncol34: 66–68, 2012.
34.
OutinenT.K., MakelaS.M., Ala-HouhalaI.O.High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in puumala hantavirus induced nephropathia epidemica.J Med Virol83: 731–737, 2011.
TorresM.I., López-CasadoM.A., LoriteP., RiosA.Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease.Clin Exp Immunol148: 419–424, 2007.
37.
SuzukiY., SudaT., YokomuraK.Serum activity of indoleamine 2,3–dioxygenase predicts prognosis of community-acquired pneumonia.J Infect63: 215–222, 2011.
38.
SekigawaT., TajimaA., HasegawaT.Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.Clin Exp Allergy39: 972–981, 2009.
39.
von BubnoffD., and BieberT.The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy.Allergy67: 718–725, 2012.
40.
GrohmannU., VolpiC., FallarinoF.Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.Nat Med13: 579–586, 2007.
41.
SwansonK.A., ZhengY., HeidlerK.M.CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.Am J Respir Cell Mol Biol30: 311–318, 2004.
42.
GrohmannU., BianchiR., OrabonaC.Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.J Immunol171: 2581–2587, 2003.
43.
FallarinoF., and GrohmannU.Indoleamine 2,3-dioxygenase: From catalyst to signaling function.Eur J Immunol42: 1932–1937, 2012.
44.
XuH., OrissT.B., FeiM.Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation.Proc Natl Acad Sci U S A105: 6690–6695, 2008.
45.
XuH., ZhangG.X., CiricB., and RostamiA.IDO: A double-edged sword for T(H)1/T(H)2 regulation.Immunol Lett121: 1–6, 2008.
von BubnoffD., FimmersR., BogdanowM.Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.Clin Exp Allergy34: 1056–1063, 2004.
50.
NakayamaT., YoshikawaM., AsakaD.Mucosal eosinophilia and recurrence of nasal polyps—New classification of chronic rhinosinusitis.Rhinology49: 392–396, 2011.
51.
BaraniukJ.N., and MaibachH.Pathophysiological classification of chronic rhinosinusitis.Respir Res6: 149, 2005.
52.
HuY., CaoP.P., LiangG.T.Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults.Laryngoscope122: 498–503, 2012.
53.
WoodruffP.G., ModrekB., ChoyD.F.T-helper type 2-driven inflammation defines major subphenotypes of asthma.Am J Respir Crit Care Med180: 388–395, 2009.
54.
SchwartzN., GrossmanA., LevyY., and SchwarzY.Correlation between eosinophil count and methacholine challenge test in asymptomatic subjects.J Asthma49: 336–341, 2012.
55.
VisserM.J., BrandP.L., BoezenH.M.Clinical and immunologic factors associated with the presence or absence of airways hyper-responsiveness in childhood asthma.Clin Exp Allergy32: 1278–1284, 2002.
56.
HolmströmM., ThelinA., Kolmodin-HedmanB., and Van HageM.Nasal complaints and signs of disease in farmers—A methodological study.Acta Otolaryngol128: 193–200, 2008.
57.
EduardW., DouwesJ., OmenaasE., and HeederikD.Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers.Thorax59: 381–386, 2004.
